Evaluation of visual, refractive outcome and changes in the ocular parameters after Eyecryl phakic IOL implementation in patients with moderate to high myopia and astigmatism: A prospective comparative study with EVO/EVO+ Visian implantable lenses

Prof MVanathi0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年4月3日

试验速览

暂无简介。

•1.Patients with myopic astigmatism within a spherical equivalent (SE) range of -3.00 to -20.00 D and a minimum astigmatism of -1.00 D, stable refraction (0.50 D or less change in the past 12 months),
•2.Minimum anterior chamber depth (ACD) from corneal endothelium of 2.8 mm,
•3.Endothelial cell count of 2,500 cells/mm2
•4.Absence of corneal ectatic diseases, corneal scars,
•5.Absence of retinal pathologies
•6.Patients willing to give written informed consent and attend all follow-up appointments

•1.Subject with previous intraocular or corneal surgery
•2.Subject with ocular condition like any cataract of any grade, glaucoma, severe dry eye, herpetic keratitis, uveitis
•3.Subject with systemic conditions like diabetes, collagen vascular diseases, immunosuppression
•4.Subject who is Pregnant or planning to start family, or lactating during the course of the evaluation
•5.Other condition associated with fluctuation of hormones
•6.Monocular subject
•7.Patient not willing to give written informed consent and attend all follow-up appointments

发起方

Prof MVanathi